NCT07055711

Brief Summary

This research aims to find the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

June 28, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 9, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

July 9, 2025

Status Verified

June 1, 2025

Enrollment Period

3 months

First QC Date

June 28, 2025

Last Update Submit

June 28, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Douleur Neuropathique 4 (DN4) Questionnaire

    The DN4 questionnaire is used to assess the neuropathic pain, if the score is \> 4 it indicates the neuropathic pain is present while \<3 than is unlikely.

    6 Month

  • visual analog scale

    The visual analog scale provide quantitative measurement of pain level which is from no pain to severe pain . The range of the scale is in between 0-10mm. 0-4 is consider as no pain, 5-44 is consider as mild pain,45-74 is moderate and \> 75 is consider as severe pain.

    6 Months

Interventions

to find out the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.

Eligibility Criteria

Age21 Years - 51 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

to find out the Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer

You may qualify if:

  • Females who have completed chemotherapy at least o1 year prior to study.
  • Aged 29-51.
  • Females who is currently employed.
  • Females who have done chemotherapy for stage 1,2,3.
  • Females who underwent chemotherapy cycles 6-8.
  • Females who are willing to participate in the study

You may not qualify if:

  • Females suffering from psychiatric conditions such as anxiety and depression.
  • Females suffering from diabetes.
  • Females who have active cancer.
  • Females with mastectomy.
  • Absent from treatment for more than 2 weeks will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lahore City

Lahore, Pakistan

Location

MeSH Terms

Conditions

Peripheral Nervous System Diseases

Condition Hierarchy (Ancestors)

Neuromuscular DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 28, 2025

First Posted

July 9, 2025

Study Start

March 3, 2025

Primary Completion

June 1, 2025

Study Completion

September 1, 2025

Last Updated

July 9, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations